Horizon Therapeutics PLC (HZNP)
23.52
+0.06 +0.26%
NASDAQ
Jul 15, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.264B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.26 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 50.28M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.56% |
| Profit Margin (Quarterly) | -11.72% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 4.348B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.151 |
| PE Ratio (TTM) | 90.46 |
| Price to Book Value | 2.891 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 54.32M |
| Return on Equity (TTM) | Upgrade |
View All HZNP News
News
-
WireHeadlineTime (ET)
-
SA Breaking News07/12 06:47
-
MT Newswires07/11 16:58
-
Business Wire07/11 16:45
-
Yahoo07/11 09:05
-
SA Breaking News07/10 12:55
-
SA Breaking News07/10 08:06
-
MT Newswires07/10 08:00
-
Business Wire07/10 07:30
-
Business Wire07/10 07:00
-
Yahoo07/09 10:11
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/08/2019 08:00 EDT | Misc | Horizon Pharma PLC Second Quarter Earnings Conference Call in 2019 |
| 08/08/2019 | Earnings | Horizon Pharma PLC Second Quarter Earnings in 2019 Release |
| 05/08/2019 08:00 EDT | Misc | Horizon Pharma PLC First Quarter Earnings Conference Call in 2019 |
| 05/08/2019 | Earnings | Horizon Pharma PLC First Quarter Earnings in 2019 Release |
| 05/02/2019 | Misc | Horizon Therapeutics PLC Annual General Meeting in 2018 |
| 02/27/2019 08:00 EST | Misc | Horizon Pharma PLC Fourth Quarter Earnings Conference Call in 2018 |
| 02/27/2019 | Earnings | Horizon Pharma PLC Fourth Quarter Earnings in 2018 Release |
| 02/27/2019 | Misc | Horizon Pharma PLC Annual Report in 2018 |
| 11/07/2018 08:00 EST | Misc | Horizon Pharma PLC Third Quarter Earnings Conference Call in 2018 |
| 11/07/2018 | Earnings | Horizon Pharma PLC Third Quarter Earnings Results in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.horizonpharma.com
- Investor Relations URL: http://ir.horizon-pharma.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Mid Cap/Blend
- Next Earnings Release: Aug. 08, 2019
- Last Earnings Release: May. 08, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the primary care segment. It markets medicines in the areas of orphan diseases, rheumatology and primary care. The majority of revenue is generated in the United States.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 23.52 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XPH | SPDR® S&P Pharmaceuticals ETF | 4.32% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.76% |
| JSJFX | JHancock Small Cap Growth R6 | 3.25% |
| PJP | Invesco Dynamic Pharmaceuticals ETF | 2.67% |
| PILL | Direxion Daily Phrmctcl&MdclBl3XShrsETF | 2.65% |
| IHE | iShares US Pharmaceuticals ETF | 1.95% |
| GTCSX | Glenmede Small Cap Equity Adv | 1.67% |
| JGRQX | JPMorgan Small Cap Growth R3 | 1.24% |
| BTEC | Principal Healthcare Innovators ETF | 1.11% |
| CEARX | Columbia Acorn Adv | 1.06% |
| TSCHX | TIAA-CREF Quant Small-Cap Equity Advisor | 0.69% |
| DFSTX | DFA US Small Cap I | 0.33% |
Excel Add-In Codes
- Name: =YCI("HZNP","name")
- Description: =YCI("HZNP","description")
- Sector: =YCI("HZNP","sector")
- Industry: =YCI("HZNP","industry")
- Est. Current Fiscal Year End: =YCI("HZNP","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- HZNP Tweets Stocktwits
Advertisement
